Next-generation sequencing (NGS) application in clinical practice requires the implementation of molecular tumor boards (MTBs). Starting from a systematic review of literature, we discuss the MTB-related key points: MTB aims and composition, types of tumors to discuss, types of molecular analyses, methods for classifying actionability, appropriate turnaround time, and cost management.

Molecular Tumor Boards in Clinical Practice

Luchini, Claudio
;
Lawlor, Rita T;Milella, Michele
;
Scarpa, Aldo
2020-01-01

Abstract

Next-generation sequencing (NGS) application in clinical practice requires the implementation of molecular tumor boards (MTBs). Starting from a systematic review of literature, we discuss the MTB-related key points: MTB aims and composition, types of tumors to discuss, types of molecular analyses, methods for classifying actionability, appropriate turnaround time, and cost management.
2020
MTB; molecular tumor board; personalized medicine; precision oncology; target therapy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1019172
Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 86
  • ???jsp.display-item.citation.isi??? 84
social impact